TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2021/12 | 2020/12 |
| Turnover |
23,848
|
22,500 | |
| Financial expenses |
72
|
10 | |
| Earnings before taxes |
701
|
571 | |
| EBITDA |
791
|
604 | |
| Total assets |
25,868
|
21,834 | |
| Current assets |
25,813
|
21,758 | |
| Current liabilities |
10,617
|
17,655 | |
| Equity capital |
4,006
|
3,571 | |
| - share capital |
20
|
20 | |
| Employees (average) |
46
|
40
|
38 |
Financial ratios
| Fiscal year | 2023/06 | 2021/12 | 2020/12 |
| Solvency |
15.5%
|
16.4% | |
| Turnover per employee |
596
|
592 | |
| Profit as a percentage of turnover |
2.9%
|
2.5% | |
| Return on assets (ROA) |
3.0%
|
2.7% | |
| Current ratio |
243.1%
|
123.2% | |
| Return on equity (ROE) |
17.5%
|
16.0% | |
| Change turnover |
1,764
|
1,100 | |
| Change turnover % |
78%
|
8%
|
5% |
| Chg. No. of employees |
6
|
2
|
3 |
| Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
| Fiscal year | 2023/06 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.